NCT02445326View on ClinicalTrials.gov

OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Chronic Allergic Conjunctivitis
Interventions
DRUG

Dexamethasone

OTHER

Placebo Vehicle

Sponsors
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Ocular Therapeutix, Inc.

INDUSTRY